Free National NPI Number Registry
Isaac Felemovicius
Home > Isaac Felemovicius
NPI Number Detailed Information
Provider Information:
| Name: | Isaac Felemovicius |
| Gender: | M |
| Provider License Number If Given: | 39558 |
NPI Information:
| NPI: | 1881649291 |
| Entity Type (Individual or Organization): |
1-ind |
| Enumeration Date: | 5/24/2006 |
| Last Update Date: | 11/7/2022 |
| Reputation Report: |
Provider Business Mailing Address:
| Address: | 9201 W BROADWAY AVE STE 601 Brooklyn Park, MN 55445 |
| Phone Number: | 7635877900 |
| Fax Number: | 7635877066 |
Provider Business Practice Location Address:
| Address: | 9825 HOSPITAL DR STE 300 Maple Grove, MN 55369 |
| Phone Number: | 7635877900 |
| Fax Number: | 7634947501 |
Provider Taxonomy:
| Primary: | 208C00000X |
| Secondary (if any): | |
| State: | MN |
Top Doctors in MN
About Isaac Felemovicius
Isaac Felemovicius ( ISAAC FELEMOVICIUS ) is A Colon & Rectal Surgery Physician in Maple Grove, MN.
The NPI Number for Isaac Felemovicius is 1881649291.
The current location address for Isaac Felemovicius is 9825 HOSPITAL DR STE 300 Maple Grove, MN 55369 and the contact number is 7635877900 and fax number is 7635877066.
The mailing address for Isaac Felemovicius is 9201 W BROADWAY AVE STE 601 Brooklyn Park, MN 55445- 7635877900 (mailing address contact number - 7635877900).
A colon and rectal surgeon is trained to diagnose and treat various diseases of the intestinal tract, colon, rectum, anal canal and perianal area by medical and surgical means. This specialist also deals with other organs and tissues (such as the liver, urinary and female reproductive system) involved with primary intestinal disease.
Provider Business Location on Map
FAQs:
What is the NPI Number for Isaac Felemovicius ?
Answer: The NPI Number for Isaac Felemovicius is 1881649291
Where is Isaac Felemovicius located?
Answer: Isaac Felemovicius is located at 9825 HOSPITAL DR STE 300 Maple Grove, MN 55369.
What is the specialty for Isaac Felemovicius ?
Answer: The Specialty of Isaac Felemovicius is A Colon & Rectal Surgery Physician.
Are there any online reviews for Isaac Felemovicius ?
Answer: Yes! Check It Now.
Are there any other health care providers in Maple Grove, MN?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Isaac Felemovicius
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
| Provider Specialty Type | Colorectal Surgery (Proctology) |
| Source of Provider Specialty | |
| Number of Medicare Part D Claims, Including Refills | 60 |
| Number of Standardized 30-Day Fills | 61 |
| Aggregate Cost Paid for All Claims | 3146.69 |
| Number of Day's Supply for All Claims | 900 |
| Number of Medicare Beneficiaries | 36 |
| Number of Claims, Including Refills, for Beneficiaries Age 65+ | |
| Including Refills, for Beneficiaries Age 65+ | |
| Beneficiaries Age 65+ | |
| Number of Day's Supply for All Claims for Beneficaries Age 65+ | |
| Number of Medicare Beneficiaries Age 65+ | |
| Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | |
| Total Claims of Brand-Name Drugs | 12 |
| Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
| Total Claims of Generic Drugs, Including Refills | 48 |
| Aggregate Cost Paid for Generic Drugs | 1208.76 |
| Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | |
| Total Claims of Other Drugs, Including Refills | 0 |
| Aggregate Cost Paid for Other Drugs | 0 |
| Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by MAPD Plans | 35 |
| Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | 1685.55 |
| Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Standalone PDP Plans | 25 |
| Aggregate Cost Paid for Claims Filled by | 1461.14 |
| Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Low-Income Subsidy | 12 |
| Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | 977.73 |
| Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | |
| Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | 48 |
| by Low-Income Subsidy | 2168.96 |
| Total Claims of Opioid Drugs, Including | 19 |
| Aggregate Cost Paid for Opioid Drugs | 232.24 |
| Opioid Claims | 14 |
| Opioid_Tot_Clms divided by the Tot_Clms | 31.666666667 |
| Total Claims of Long-Acting Opioid Drugs | 0 |
| Aggregate Cost Paid for Long-Acting Opioid | 0 |
| Number of Day's Supply of All Long-Acting | 0 |
| Long-Acting Opioid Claims | 0 |
| Opioid_LA_Tot_Clms divided by the | 0 |
| Total Claims of Antibiotic Drugs, Including | |
| Aggregate Cost Paid for Antibiotic Drugs | |
| Antibiotic Claims | |
| Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | * |
| Including Refills, for Beneficiaries Age 65+ | |
| Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | |
| Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
| Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | |
| Average Age of Beneficiaries | 72.083333333 |
| Number of Beneficiaries Age Less Than 65 | |
| Number of Beneficiaries Age 65 to 74 | |
| Number of Beneficiaries Age 75 to 84 | |
| Number of Female Beneficiaries | 17 |
| Number of Male Beneficiaries | 19 |
| Number of Non-Hispanic White | 33 |
| Number of Black or African American | 0 |
| Number of Asian Pacific Islander | |
| Number of Hispanic Beneficiaries | 0 |
| Number of American Indian/Alaskan NativeBeneficiaries | 0 |
| Number of Beneficiaries with Race Not | |
| Only Entitlement | |
| Average Hierarchical Condition Category | 1.2752997993 |
More Providers in maple-grove , mn
isaac felemovicius in Other Directories
Provider don't have other directory link yet.
